Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1221011

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1221011

Rising demand for drug testing drives North America Toxicology Laboratories market growth

PUBLISHED:
PAGES: 169 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7600
PDF (Corporate User License)
USD 10600

Add to Cart

North America Toxicology Laboratories Market: Scope of Report

The latest publication by Persistence Market Research on the North America toxicology laboratories market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for toxicology laboratories and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the North America toxicology laboratories market. Shareholders in the toxicology laboratories market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the North America toxicology laboratories market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the toxicology laboratories market offers information divided into five important segments - drug class, product, sample, end user and country. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

Alcohol

Amphetamines

Barbiturates

Benzodiazepines

Illicit Drugs

Opiates/Opioids

Tricyclic's Antidepressants

Z Drugs

Product

Reagent and Kits

ELISA

PCR

Enzyme Multiplied Immunoassay Technique (EMIT)

Radio Immuno-sorbent Assay (RIA)

Instruments

Immunochemistry Analyzers

PCR Machine

Gas Chromatography/Mass Spectrometry (GS/MS)

High Performance Liquid Chromatography(HPLC)

Sample

Urine

Blood

Hair

Oral Fluid

End User

Hospitals

Clinics

Diagnostic Laboratories

Forensic Laboratories

Rehabilitation Centers

Country

U.S.

Canada

Key Questions Answered in Report:

Which country will continue to remain the most profitable markets for North America toxicology laboratories over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed country?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the North America toxicology laboratories market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the North America toxicology laboratories market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the North America toxicology laboratories market are more accurate and reliable.

Product Code: PMRREP9707

Table of Contents

1. Executive Summary

  • 1.1. North America Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate/Usage Analysis - Key Statistics
  • 4.2. Value Chain Analysis
  • 4.3. Regulatory Scenario
  • 4.4. Product USP Analysis
  • 4.5. Pipeline Assessment
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis
  • 4.8. Key Promotional Strategies, By Key Players

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. North America GDP Growth Outlook
    • 5.1.2. North America Healthcare Outlook
    • 5.1.3. North America Drug Abuse Testing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Product Adoption Rate
    • 5.2.2. Prevalence of Chronic Diseases
    • 5.2.3. Strategic Collaborations
    • 5.2.4. Adoption Rate
    • 5.2.5. Cost of Product
    • 5.2.6. Treatment Regime
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Drug Class
    • 6.1.2. By Product
    • 6.1.3. By Sample
    • 6.1.4. By End User
    • 6.1.5. By Country
  • 6.2. 2022 Market Scenario

7. North America Toxicology Laboratories Market Demand (in Value US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
  • 7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By Drug Class

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis, by Drug Class, 2016-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Drug Class, 2023-2033
    • 8.3.1. Alcohol
    • 8.3.2. Amphetamines
    • 8.3.3. Barbiturates
    • 8.3.4. Benzodiazepines
    • 8.3.5. Illicit Drugs
    • 8.3.6. Opiates/Opioids
    • 8.3.7. Tricyclic's Antidepressants
    • 8.3.8. Z Drugs
  • 8.4. Market Attractiveness Analysis, by Drug Class

9. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By Product

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, by Product, 2016-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2023-2033
    • 9.3.1. Reagent and Kits
      • 9.3.1.1. ELISA
      • 9.3.1.2. PCR
      • 9.3.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 9.3.1.4. Radio Immuno-sorbent Assay (RIA)
    • 9.3.2. Instruments
      • 9.3.2.1. Immunochemistry Analyzers
      • 9.3.2.2. PCR Machine
      • 9.3.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 9.3.2.4. High Performance Liquid Chromatography(HPLC)
  • 9.4. Market Attractiveness Analysis, by Product

10. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By Sample

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, by Sample, 2016-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Sample, 2023-2033
    • 10.3.1. Urine
    • 10.3.2. Blood
    • 10.3.3. Hair
    • 10.3.4. Oral Fluid
  • 10.4. Market Attractiveness Analysis, by Sample

11. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2016-2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2023-2033
    • 11.3.1. Hospitals
    • 11.3.2. Clinics
    • 11.3.3. Diagnostic Laboratories
    • 11.3.4. Forensic Laboratories
    • 11.3.5. Rehabilitation Centers
  • 11.4. Market Attractiveness Analysis, by End User

12. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By Country

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis, by Country, 2016-2022
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Country 2023-2033
    • 12.3.1. U.S.
    • 12.3.2. Canada
  • 12.4. Market Attractiveness Analysis, by Country

13. U.S. Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2016-2022
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
    • 13.3.1. By Drug Class
    • 13.3.2. By Product
    • 13.3.3. By Sample
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Drug Class
    • 13.4.2. By Product
    • 13.4.3. By Sample
    • 13.4.4. By End User

14. Canada Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2016-2022
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
    • 14.3.1. By Drug Class
    • 14.3.2. By Product
    • 14.3.3. By Sample
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Drug Class
    • 14.4.2. By Product
    • 14.4.3. By Sample
    • 14.4.4. By End User

15. Market Structure Analysis

  • 15.1. Market Analysis, by Tier of Companies
  • 15.2. Market Share Analysis of Top Players
  • 15.3. Market Concentration
  • 15.4. Market Presence Analysis

16. Competition Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Deep Dive
    • 16.2.1. Thermo Fisher Scientific, Inc.
      • 16.2.1.1. Overview
      • 16.2.1.2. Product Portfolio
      • 16.2.1.3. Sales Footprint
      • 16.2.1.4. Key Financials
      • 16.2.1.5. SWOT Analysis
      • 16.2.1.6. Strategy Overview
        • 16.2.1.6.1. Marketing Strategy
        • 16.2.1.6.2. Product Strategy
        • 16.2.1.6.3. Channel Strategy
    • 16.2.2. Danaher Corporation
      • 16.2.2.1. Overview
      • 16.2.2.2. Product Portfolio
      • 16.2.2.3. Sales Footprint
      • 16.2.2.4. Key Financials
      • 16.2.2.5. SWOT Analysis
      • 16.2.2.6. Strategy Overview
        • 16.2.2.6.1. Marketing Strategy
        • 16.2.2.6.2. Product Strategy
        • 16.2.2.6.3. Channel Strategy
    • 16.2.3. Agilent Technologies
      • 16.2.3.1. Overview
      • 16.2.3.2. Product Portfolio
      • 16.2.3.3. Sales Footprint
      • 16.2.3.4. Key Financials
      • 16.2.3.5. SWOT Analysis
      • 16.2.3.6. Strategy Overview
        • 16.2.3.6.1. Marketing Strategy
        • 16.2.3.6.2. Product Strategy
        • 16.2.3.6.3. Channel Strategy
    • 16.2.4. Alere, Inc
      • 16.2.4.1. Overview
      • 16.2.4.2. Product Portfolio
      • 16.2.4.3. Sales Footprint
      • 16.2.4.4. Key Financials
      • 16.2.4.5. SWOT Analysis
      • 16.2.4.6. Strategy Overview
        • 16.2.4.6.1. Marketing Strategy
        • 16.2.4.6.2. Product Strategy
        • 16.2.4.6.3. Channel Strategy
    • 16.2.5. Bio Rad Laboratories Inc
      • 16.2.5.1. Overview
      • 16.2.5.2. Product Portfolio
      • 16.2.5.3. Sales Footprint
      • 16.2.5.4. Key Financials
      • 16.2.5.5. SWOT Analysis
      • 16.2.5.6. Strategy Overview
        • 16.2.5.6.1. Marketing Strategy
        • 16.2.5.6.2. Product Strategy
        • 16.2.5.6.3. Channel Strategy
    • 16.2.6. Neogen Corporation
      • 16.2.6.1. Overview
      • 16.2.6.2. Product Portfolio
      • 16.2.6.3. Sales Footprint
      • 16.2.6.4. Key Financials
      • 16.2.6.5. SWOT Analysis
      • 16.2.6.6. Strategy Overview
        • 16.2.6.6.1. Marketing Strategy
        • 16.2.6.6.2. Product Strategy
        • 16.2.6.6.3. Channel Strategy
    • 16.2.7. Bruker
      • 16.2.7.1. Overview
      • 16.2.7.2. Product Portfolio
      • 16.2.7.3. Sales Footprint
      • 16.2.7.4. Key Financials
      • 16.2.7.5. SWOT Analysis
      • 16.2.7.6. Strategy Overview
        • 16.2.7.6.1. Marketing Strategy
        • 16.2.7.6.2. Product Strategy
        • 16.2.7.6.3. Channel Strategy
    • 16.2.8. WATERS
      • 16.2.8.1. Overview
      • 16.2.8.2. Product Portfolio
      • 16.2.8.3. Sales Footprint
      • 16.2.8.4. Key Financials
      • 16.2.8.5. SWOT Analysis
      • 16.2.8.6. Strategy Overview
        • 16.2.8.6.1. Marketing Strategy
        • 16.2.8.6.2. Product Strategy
        • 16.2.8.6.3. Channel Strategy
    • 16.2.9. Redwood Toxicology Laboratory
      • 16.2.9.1. Overview
      • 16.2.9.2. Product Portfolio
      • 16.2.9.3. Sales Footprint
      • 16.2.9.4. Key Financials
      • 16.2.9.5. SWOT Analysis
      • 16.2.9.6. Strategy Overview
        • 16.2.9.6.1. Marketing Strategy
        • 16.2.9.6.2. Product Strategy
        • 16.2.9.6.3. Channel Strategy
    • 16.2.10. Laboratory Corporation of America ©Holdings (MedTox Laboratories, Inc.)
      • 16.2.10.1. Overview
      • 16.2.10.2. Product Portfolio
      • 16.2.10.3. Sales Footprint
      • 16.2.10.4. Key Financials
      • 16.2.10.5. SWOT Analysis
      • 16.2.10.6. Strategy Overview
        • 16.2.10.6.1. Marketing Strategy
        • 16.2.10.6.2. Product Strategy
        • 16.2.10.6.3. Channel Strategy
    • 16.2.11. Principle Laboratory
      • 16.2.11.1. Overview
      • 16.2.11.2. Product Portfolio
      • 16.2.11.3. Sales Footprint
      • 16.2.11.4. Key Financials
      • 16.2.11.5. SWOT Analysis
      • 16.2.11.6. Strategy Overview
        • 16.2.11.6.1. Marketing Strategy
        • 16.2.11.6.2. Product Strategy
        • 16.2.11.6.3. Channel Strategy
    • 16.2.12. Pacific Toxicology Laboratories
      • 16.2.12.1. Overview
      • 16.2.12.2. Product Portfolio
      • 16.2.12.3. Sales Footprint
      • 16.2.12.4. Key Financials
      • 16.2.12.5. SWOT Analysis
      • 16.2.12.6. Strategy Overview
        • 16.2.12.6.1. Marketing Strategy
        • 16.2.12.6.2. Product Strategy
        • 16.2.12.6.3. Channel Strategy
    • 16.2.13. Medical Toxicology Laboratory, LLC
      • 16.2.13.1. Overview
      • 16.2.13.2. Product Portfolio
      • 16.2.13.3. Sales Footprint
      • 16.2.13.4. Key Financials
      • 16.2.13.5. SWOT Analysis
      • 16.2.13.6. Strategy Overview
        • 16.2.13.6.1. Marketing Strategy
        • 16.2.13.6.2. Product Strategy
        • 16.2.13.6.3. Channel Strategy
    • 16.2.14. ITR Canada
      • 16.2.14.1. Overview
      • 16.2.14.2. Product Portfolio
      • 16.2.14.3. Sales Footprint
      • 16.2.14.4. Key Financials
      • 16.2.14.5. SWOT Analysis
      • 16.2.14.6. Strategy Overview
        • 16.2.14.6.1. Marketing Strategy
        • 16.2.14.6.2. Product Strategy
        • 16.2.14.6.3. Channel Strategy
    • 16.2.15. NMS Labs
      • 16.2.15.1. Overview
      • 16.2.15.2. Product Portfolio
      • 16.2.15.3. Sales Footprint
      • 16.2.15.4. Key Financials
      • 16.2.15.5. SWOT Analysis
      • 16.2.15.6. Strategy Overview
        • 16.2.15.6.1. Marketing Strategy
        • 16.2.15.6.2. Product Strategy
        • 16.2.15.6.3. Channel Strategy
    • 16.2.16. National Toxicology Labs, Inc
      • 16.2.16.1. Overview
      • 16.2.16.2. Product Portfolio
      • 16.2.16.3. Sales Footprint
      • 16.2.16.4. Key Financials
      • 16.2.16.5. SWOT Analysis
      • 16.2.16.6. Strategy Overview
        • 16.2.16.6.1. Marketing Strategy
        • 16.2.16.6.2. Product Strategy
        • 16.2.16.6.3. Channel Strategy
    • 16.2.17. BATTS Laboratories
      • 16.2.17.1. Overview
      • 16.2.17.2. Product Portfolio
      • 16.2.17.3. Sales Footprint
      • 16.2.17.4. Key Financials
      • 16.2.17.5. SWOT Analysis
      • 16.2.17.6. Strategy Overview
        • 16.2.17.6.1. Marketing Strategy
        • 16.2.17.6.2. Product Strategy
        • 16.2.17.6.3. Channel Strategy
    • 16.2.18. Marshfield Clinic
      • 16.2.18.1. Overview
      • 16.2.18.2. Product Portfolio
      • 16.2.18.3. Sales Footprint
      • 16.2.18.4. Key Financials
      • 16.2.18.5. SWOT Analysis
      • 16.2.18.6. Strategy Overview
        • 16.2.18.6.1. Marketing Strategy
        • 16.2.18.6.2. Product Strategy
        • 16.2.18.6.3. Channel Strategy
    • 16.2.19. TOTAL TOXICOLOGY LABS
      • 16.2.19.1. Overview
      • 16.2.19.2. Product Portfolio
      • 16.2.19.3. Sales Footprint
      • 16.2.19.4. Key Financials
      • 16.2.19.5. SWOT Analysis
      • 16.2.19.6. Strategy Overview
        • 16.2.19.6.1. Marketing Strategy
        • 16.2.19.6.2. Product Strategy
        • 16.2.19.6.3. Channel Strategy
    • 16.2.20. Clinical Reference Laboratory, Inc.
      • 16.2.20.1. Overview
      • 16.2.20.2. Product Portfolio
      • 16.2.20.3. Sales Footprint
      • 16.2.20.4. Key Financials
      • 16.2.20.5. SWOT Analysis
      • 16.2.20.6. Strategy Overview
        • 16.2.20.6.1. Marketing Strategy
        • 16.2.20.6.2. Product Strategy
        • 16.2.20.6.3. Channel Strategy
    • 16.2.21. Life Brite Labs.
      • 16.2.21.1. Overview
      • 16.2.21.2. Product Portfolio
      • 16.2.21.3. Sales Footprint
      • 16.2.21.4. Key Financials
      • 16.2.21.5. SWOT Analysis
      • 16.2.21.6. Strategy Overview
        • 16.2.21.6.1. Marketing Strategy
        • 16.2.21.6.2. Product Strategy
        • 16.2.21.6.3. Channel Strategy
    • 16.2.22. Product Safety Labs
      • 16.2.22.1. Overview
      • 16.2.22.2. Product Portfolio
      • 16.2.22.3. Sales Footprint
      • 16.2.22.4. Key Financials
      • 16.2.22.5. SWOT Analysis
      • 16.2.22.6. Strategy Overview
        • 16.2.22.6.1. Marketing Strategy
        • 16.2.22.6.2. Product Strategy
        • 16.2.22.6.3. Channel Strategy
    • 16.2.23. Lexar Labs
      • 16.2.23.1. Overview
      • 16.2.23.2. Product Portfolio
      • 16.2.23.3. Sales Footprint
      • 16.2.23.4. Key Financials
      • 16.2.23.5. SWOT Analysis
      • 16.2.23.6. Strategy Overview
        • 16.2.23.6.1. Marketing Strategy
        • 16.2.23.6.2. Product Strategy
        • 16.2.23.6.3. Channel Strategy
    • 16.2.24. Eurofins Scientific
      • 16.2.24.1. Overview
      • 16.2.24.2. Product Portfolio
      • 16.2.24.3. Sales Footprint
      • 16.2.24.4. Key Financials
      • 16.2.24.5. SWOT Analysis
      • 16.2.24.6. Strategy Overview
        • 16.2.24.6.1. Marketing Strategy
        • 16.2.24.6.2. Product Strategy
        • 16.2.24.6.3. Channel Strategy
    • 16.2.25. Aegis Sciences Corporation
      • 16.2.25.1. Overview
      • 16.2.25.2. Product Portfolio
      • 16.2.25.3. Sales Footprint
      • 16.2.25.4. Key Financials
      • 16.2.25.5. SWOT Analysis
      • 16.2.25.6. Strategy Overview
        • 16.2.25.6.1. Marketing Strategy
        • 16.2.25.6.2. Product Strategy
        • 16.2.25.6.3. Channel Strategy
    • 16.2.26. Enzo Life Sciences, Inc.
      • 16.2.26.1. Overview
      • 16.2.26.2. Product Portfolio
      • 16.2.26.3. Sales Footprint
      • 16.2.26.4. Key Financials
      • 16.2.26.5. SWOT Analysis
      • 16.2.26.6. Strategy Overview
        • 16.2.26.6.1. Marketing Strategy
        • 16.2.26.6.2. Product Strategy
        • 16.2.26.6.3. Channel Strategy
    • 16.2.27. Immunalysis Corporation
      • 16.2.27.1. Overview
      • 16.2.27.2. Product Portfolio
      • 16.2.27.3. Sales Footprint
      • 16.2.27.4. Key Financials
      • 16.2.27.5. SWOT Analysis
      • 16.2.27.6. Strategy Overview
        • 16.2.27.6.1. Marketing Strategy
        • 16.2.27.6.2. Product Strategy
        • 16.2.27.6.3. Channel Strategy
    • 16.2.28. Vala Sciences, Inc.
      • 16.2.28.1. Overview
      • 16.2.28.2. Product Portfolio
      • 16.2.28.3. Sales Footprint
      • 16.2.28.4. Key Financials
      • 16.2.28.5. SWOT Analysis
      • 16.2.28.6. Strategy Overview
        • 16.2.28.6.1. Marketing Strategy
        • 16.2.28.6.2. Product Strategy
        • 16.2.28.6.3. Channel Strategy
    • 16.2.29. Mattek Corporation
      • 16.2.29.1. Overview
      • 16.2.29.2. Product Portfolio
      • 16.2.29.3. Sales Footprint
      • 16.2.29.4. Key Financials
      • 16.2.29.5. SWOT Analysis
      • 16.2.29.6. Strategy Overview
        • 16.2.29.6.1. Marketing Strategy
        • 16.2.29.6.2. Product Strategy
        • 16.2.29.6.3. Channel Strategy
    • 16.2.30. MedTest Dx
      • 16.2.30.1. Overview
      • 16.2.30.2. Product Portfolio
      • 16.2.30.3. Sales Footprint
      • 16.2.30.4. Key Financials
      • 16.2.30.5. SWOT Analysis
      • 16.2.30.6. Strategy Overview
        • 16.2.30.6.1. Marketing Strategy
        • 16.2.30.6.2. Product Strategy
        • 16.2.30.6.3. Channel Strategy
    • 16.2.31. Pyxis Laboratories Inc
      • 16.2.31.1. Overview
      • 16.2.31.2. Product Portfolio
      • 16.2.31.3. Sales Footprint
      • 16.2.31.4. Key Financials
      • 16.2.31.5. SWOT Analysis
      • 16.2.31.6. Strategy Overview
        • 16.2.31.6.1. Marketing Strategy
        • 16.2.31.6.2. Product Strategy
        • 16.2.31.6.3. Channel Strategy
    • 16.2.32. Air Science® USA LLC
      • 16.2.32.1. Overview
      • 16.2.32.2. Product Portfolio
      • 16.2.32.3. Sales Footprint
      • 16.2.32.4. Key Financials
      • 16.2.32.5. SWOT Analysis
      • 16.2.32.6. Strategy Overview
        • 16.2.32.6.1. Marketing Strategy
        • 16.2.32.6.2. Product Strategy
        • 16.2.32.6.3. Channel Strategy

17. Assumptions and Acronyms Used

18. Research Methodology

Product Code: PMRREP9707

List of Tables

  • Table 01: North America Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Drug Class
  • Table 02: North America Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Product
  • Table 03: North America Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Sample
  • Table 04: North America Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by End User
  • Table 05: North America Toxicology Laboratories Market Value (US$ Mn) Analysis 2016-2023 and Forecast 2023-2033, by Country
  • Table 06: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Drug Class
  • Table 07: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Product
  • Table 08: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Sample
  • Table 09: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by End User
  • Table 10: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Drug Class
  • Table 11: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Product
  • Table 12: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Sample
  • Table 13: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by End User

List of Figures

  • Figure 01: North America Toxicology Laboratories Market Value (US$ Mn) Analysis, 2016-2022
  • Figure 02: North America Toxicology Laboratories Market Forecast & Y-o-Y Growth, 2023-2033
  • Figure 03: North America Toxicology Laboratories Market Absolute $ Opportunity (US$ Mn) Analysis, 2023-2033
  • Figure 04: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by Drug Class
  • Figure 05: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by Drug Class
  • Figure 06: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by Drug Class
  • Figure 07: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by Product
  • Figure 08: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by Product
  • Figure 09: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by Product
  • Figure 10: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by Sample
  • Figure 11: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by Sample
  • Figure 12: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by Sample
  • Figure 13: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by End User
  • Figure 14: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by End User
  • Figure 15: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by End User
  • Figure 16: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by Country
  • Figure 17: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by Country
  • Figure 18: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by Country
  • Figure 19: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis, 2016-2022
  • Figure 20: U.S. Toxicology Laboratories Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 21: U.S. Toxicology Laboratories Market Value Share, By Drug Class (2023 E)
  • Figure 22: U.S. Toxicology Laboratories Market Value Share, By Product (2023 E)
  • Figure 23: U.S. Toxicology Laboratories Market Value Share, By Sample (2023 E)
  • Figure 24: U.S. Toxicology Laboratories Market Value Share, By End User (2023 E)
  • Figure 25: U.S. Toxicology Laboratories Market Attractiveness Analysis By Drug Class, 2023-2033
  • Figure 26: U.S. Toxicology Laboratories Market Attractiveness Analysis By Product, 2023-2033
  • Figure 27: U.S. Toxicology Laboratories Market Attractiveness Analysis By Sample, 2023-2033
  • Figure 28: U.S. Toxicology Laboratories Market Attractiveness Analysis By End User, 2023-2033
  • Figure 29: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis, 2016-2022
  • Figure 30: Canada Toxicology Laboratories Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 31: Canada Toxicology Laboratories Market Value Share, By Drug Class (2023 E)
  • Figure 32: Canada Toxicology Laboratories Market Value Share, By Product (2023 E)
  • Figure 33: Canada Toxicology Laboratories Market Value Share, By Sample (2023 E)
  • Figure 34: Canada Toxicology Laboratories Market Value Share, By End User (2023 E)
  • Figure 35: Canada Toxicology Laboratories Market Attractiveness Analysis By Drug Class, 2023-2033
  • Figure 36: Canada Toxicology Laboratories Market Attractiveness Analysis By Product, 2023-2033
  • Figure 37: Canada Toxicology Laboratories Market Attractiveness Analysis By Sample, 2023-2033
  • Figure 38: Canada Toxicology Laboratories Market Attractiveness Analysis By End User, 2023-2033
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!